Volume | 191,057 |
|
|||||
News | - | ||||||
Day High | 27.78 | Low High |
|||||
Day Low | 26.61 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Protagonist Therapeutics Inc | PTGX | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
26.71 | 26.61 | 27.78 | 26.61 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
5,090 | 191,057 | $ 27.25 | $ 5,206,059 | - | 13.72 - 33.34 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
15:47:38 | 13 | $ 26.82 | USD |
Protagonist Therapeutics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
1.58B | 58.27M | - | 60M | -78.96M | -1.35 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Protagonist Therapeutics News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PTGX Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 26.30 | 27.78 | 24.79 | 25.78 | 444,902 | 0.53 | 2.02% |
1 Month | 28.42 | 29.27 | 24.79 | 27.56 | 551,008 | -1.59 | -5.59% |
3 Months | 26.48 | 33.34 | 24.79 | 28.22 | 669,519 | 0.35 | 1.32% |
6 Months | 14.32 | 33.34 | 13.72 | 23.82 | 707,441 | 12.51 | 87.36% |
1 Year | 23.91 | 33.34 | 13.72 | 23.06 | 808,792 | 2.92 | 12.21% |
3 Years | 29.36 | 50.54 | 6.91 | 21.03 | 981,970 | -2.53 | -8.62% |
5 Years | 10.30 | 50.54 | 4.47 | 19.76 | 761,415 | 16.53 | 160.49% |
Protagonist Therapeutics Description
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidate to address medical needs. The Company operates and manages its business as one operating segment. |